Salt Lake-based BioMicro Systems Inc. said Wednesday that Michael Feldman has been appointed chief executive officer.
Feldman previously was general manager at Northwest Toxicology, which later was acquired by LabOne Inc. At LabOne, Feldman served as vice president of business development.
Privately held BioMicro Systems was founded in 2000 and is focused on the development and commercialization of biological research products based on its microfluid and microarray technologies.
The U.S. housing market is historically overvalued. Moody’s says these cities may see prices drop up to 10%